Stocks to Watch: iBio, DoorDash, DraftKings, Moderna
16 Fevereiro 2023 - 9:04PM
Dow Jones News
By Sabela Ojea
iBio Inc. on Thursday disclosed that the MUC16 protein is the
target of its latest immune-oncology program. Shares surged 129% in
after-hours trading.
DoorDash Inc. reported a 40% rise in revenue in its latest
quarter, as consumers spent more on deliveries of food and
household essentials even as prices rose and more restaurants
reopened. Shares climbed 5.6% in after-hours trading.
DraftKings Inc. raised its fiscal-year 2023 guidance after
reporting a surge in fourth-quarter revenue. Shares of the online
sports-betting company increased 5.1% in after-hours trading.
Moderna Inc. posted mixed results for an experimental Moderna
vaccine against seasonal influenza in a clinical trial of more than
6,100 adults in the southern hemisphere. Shares of the
pharmaceutical company edged down 5.9% in after-hours trading.
Write to Sabela Ojea at sabela.ojea@wsj.com; @sabelaojeaguix
(END) Dow Jones Newswires
February 16, 2023 18:49 ET (23:49 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.
DraftKings (NASDAQ:DKNG)
Gráfico Histórico do Ativo
De Set 2024 até Out 2024
DraftKings (NASDAQ:DKNG)
Gráfico Histórico do Ativo
De Out 2023 até Out 2024